About this trial
Neonatal jaundice is a physiological process characterized by a yellow coloration of the skin and mucous membranes linked to an increase in a pigment: bilirubin. However, an excessive accumulation of bilirubin can lead to neurological complications: kernicterus. The screening for pathological jaundice is carried out through daily measurements of transcutaneous bilirubin using non-invasive devices (bilirubinometers). The diagnosis is made by measuring blood bilirubin levels and comparing them with reference curves. In newborns with dark skin, transcutaneous bilirubin measurements may be inaccurate because melanin interferes with the bilirubinometers.
Eligibility criteria
Qualifiers
Born from 36 weeks of amenorrhea
Hospitalized in the postnatal ward or kangaroo care unit
Requiring a blood test for bilirubin analysed at the Cochin laboratory.
No objection from both holders of parental authority.
Disqualifiers
Having received phototherapy treatment within the last 24 hours
Trial design
Treatments tested in this trial
- Skin color assessment
Treatment groups
Sponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
URC-CIC Paris Descartes Necker Cochin
Collaborator